Personalized medicine - Statistics & Facts

Today, most patients are still treated after same uniform patterns. For example, a large number of patients with the same disease will get the exact same treatment, and if efficiency is absent, they will be switched to the next given type of treatment. This often time-wasting trail-and-error style is typical for classical treatments. To put it simply, the focusing on the special characteristics of every individual is barely existent. That is where personalized medicine steps in.

Share of oncology drugs in development which are personalized as of 2015
73%

Number of personalized medicines available in the U.S. in 2020
***

Personalized medicine investment growth in the U.S. in 2011-2015
53%

Editor’s Picks
Editor’s Picks
Current statistics on this topic

Industry & Market

Technological advances in the genome sequencing area 2003-2020

Pharmaceuticals

Number of personalized medicines in the U.S. 2008-2020

Health Professionals & Hospitals

Healthcare professionals about their organization's focus 2016 vs. 2021

Premises

Patients without improvement after taking selected top selling drugs 2015
Patients without improvement after taking selected top selling drugs 2015
Number of patients with no improvement after taking selected top selling drugs worldwide as of 2015 (per every patient with improvement)*
Share of patients for which a certain drug is ineffective by therapy class
Share of patients for which a certain drug is ineffective by therapy class
Percentage of patients for which a certain drug is ineffective, by therapy class
Technological advances in the genome sequencing area 2003-2020
Technological advances in the genome sequencing area 2003-2020
Selected technological advances in the genome sequencing area in 2003, 2015, and 2020
Technological advances in genomic medicine 2003-2020
Technological advances in genomic medicine 2003-2020
Selected technological advances in genomic medicine in 2003, 2015, and 2020
Number of discovered genes with known disease-causing mutations 2003 and 2015
Number of discovered genes with known disease-causing mutations 2003 and 2015
Number of discovered genes with known phenotypes/disease-causing mutations as of 2003 and 2015
Patients whose tumors are driven by genetic mutations by cancer type 2016
Patients whose tumors are driven by genetic mutations by cancer type 2016
Percentage of patients whose tumors are driven by certain genetic mutations as of 2016, by cancer type
Incidence of biomarker positivity cancer patients 2017 U.S. by type
Incidence of biomarker positivity cancer patients 2017 U.S. by type
Percentage of U.S. patients with selected cancer types with positivity for newly available biomarkers as of 2017*

Biomarkers

U.S. development phase success rates for drugs with and without biomarkers 2011-2020
U.S. development phase success rates for drugs with and without biomarkers 2011-2020
Probability of success for new drugs in the U.S. with and without selection biomarkers by development phase between 2011 and 2020
Biomarker technologies: global market forecast 2024 and 2029
Biomarker technologies: global market forecast 2024 and 2029
Global biomarker market forecast for 2024 and 2029 (in billion U.S. dollars)
Total market size for biomarkers in the United States 2015-2024
Total market size for biomarkers in the United States 2015-2024
Total biomarkers market in the United States from 2015 to 2024 (in million U.S. dollars)*
Market size for biomarkers in the United States by disease 2015-2024
Market size for biomarkers in the United States by disease 2015-2024
Market size for biomarkers in the United States from 2015 to 2024, by condition (in million U.S. dollars)*
Market size for cancer biomarkers in the United States by application 2015-2024
Market size for cancer biomarkers in the United States by application 2015-2024
Cancer biomarkers market in the United States from 2015 to 2024, by application (in billion U.S. dollars)*
Top sequencing companies worldwide by revenue 2017
Top sequencing companies worldwide by revenue 2017
Leading sequencing companies worldwide in 2017, by revenue (in million U.S. dollars)

PM key data

Total global market for personalized medicine 2022-2032
Total global market for personalized medicine 2022-2032
Total global market for personalized medicine from 2022 to 2032 (in billion U.S. dollars)
Personalized medicine - investment growth 2006-2015
Personalized medicine - investment growth 2006-2015
Investment growth in personalized medicine in the United States between 2006 and 2015
Number of personalized medicines in the U.S. 2008-2020
Number of personalized medicines in the U.S. 2008-2020
Number of personalized medicines available in the U.S. from 2008 to 2020*
Personalized medicines as percent of new molecular entities 2014-2024
Personalized medicines as percent of new molecular entities 2014-2024
Personalized medicines as a percentage of FDA approved new molecular entities from 2014 to 2024
Personalized medicine in development by type 2015
Personalized medicine in development by type 2015
Percentage of personalized medicines in development as of 2015, by type

Views on PM

Healthcare professionals about their organization's focus 2016 vs. 2021
Healthcare professionals about their organization's focus 2016 vs. 2021
Opinions of healthcare professionals about their organization's focus in 2016 and 2021
Healthcare organizations personalized medicine primary focus 2016 vs. 2018
Healthcare organizations personalized medicine primary focus 2016 vs. 2018
Personalized medicine program primary focuses of healthcare organizations in 2016 and 2018
U.S. adults that have not heard of personalized medicine 2018
U.S. adults that have not heard of personalized medicine 2018
Percentage of U.S. adults that have not heard of personalized medicine or precision medicine as of 2018
Reactions among U.S. adults to description of personalized medicine 2018
Reactions among U.S. adults to description of personalized medicine 2018
Percentage of U.S. adults that reacted positively after learning the description of personalized medicine as of 2018
U.S. opinions on insurance coverage of personalized tests and treatments in 2018
U.S. opinions on insurance coverage of personalized tests and treatments in 2018
Percentage of U.S. adults that believe insurance companies should cover personalized tests and treatments as of 2018
Major concerns among adults regarding personalized medicine in the U.S. in 2018
Major concerns among adults regarding personalized medicine in the U.S. in 2018
Percentage of U.S. adults with major concerns regarding personalized medicine as of 2018

Outlook

Global market for personalized medicine by product 2015-2022
Global market for personalized medicine by product 2015-2022
Global market for personalized medicine from 2015 to 2022, by product (in billion U.S. dollars)*
Size of global DNA sequencing market in 2023 and 2029
Size of global DNA sequencing market in 2023 and 2029
Size of the global DNA sequencing market in 2023 and a forecast for 2029 (in million U.S. dollars)
Size of global companion diagnostics market 2014-2024
Size of global companion diagnostics market 2014-2024
Size of the global companion diagnostics market from 2014 to 2024 (in million U.S. dollars)
Global next generation sequencing market share forecast by technology 2024
Global next generation sequencing market share forecast by technology 2024
Global next generation sequencing market share in 2016 and 2024, by technology

Share of oncology drugs in development which are personalized as of 2015
73%

Number of personalized medicines available in the U.S. in 2020
***

Personalized medicine investment growth in the U.S. in 2011-2015
53%

Key figures

The most important key figures provide you with a compact summary of the topic of "Personalized medicine" and take you straight to the corresponding statistics.

- Global estimated biomarker market size in 2024
- 51.5bn USD
Log in or register to access full data.
Detailed statistics
Biomarker technologies: global market forecast 2024 and 2029
- Probability of success for a drug in development with biomarkers between phase I and approval
- ****%
Log in or register to access full data.
Detailed statistics
U.S. development phase success rates for drugs with and without biomarkers 2011-2020
- U.S. biomarker market in 2016
- 10.4bn USD
Log in or register to access full data.
Detailed statistics
Total market size for biomarkers in the United States 2015-2024

- Total global personalized medicine market forecast for 2026
- 715bn USD
Log in or register to access full data.
Detailed statistics
Total global market for personalized medicine 2022-2032
- Total global personalized medicine diagnostics market forecast for 2022
- 0.2bn USD
Log in or register to access full data.
Detailed statistics
Global market for personalized medicine by product 2015-2022
- Global cardiac biomarker market share of the Americas in 2016
- ****%
Log in or register to access full data.
Detailed statistics
Global distribution of cardiac biomarker market by region 2016